
Psychiatr Serv 55:892-900, August 2004
© 2004 American Psychiatric Association
A Comparison of Type 2 Diabetes Outcomes Among Persons With and Without Severe Mental Illnesses
Lisa B. Dixon, M.D., M.P.H.,
Julie A. Kreyenbuhl, Ph.D.,
Faith B. Dickerson, Ph.D., M.D.,
Thomas W. Donner, M.D.,
Clayton H. Brown, Ph.D.,
Karen Wolheiter,
Leticia Postrado, Ph.D.,
Richard W. Goldberg, Ph.D.,
LiJuan Fang, M.S.,
Christopher Marano, M.D. and
Erick Messias, M.D., M.P.H.
OBJECTIVE: Type 2 diabetes is an important comorbid medical condition associated with schizophrenia. The objective of this study was to compare glycosylated hemoglobin (HbA1c) levels of patients who had type 2 diabetes and schizophrenia with those of patients who had type 2 diabetes and major mood disorders and those who had type 2 diabetes but who did not have severe mental illness. METHODS: A sample of 300 patients with type 2 diabetes was recruited from community mental health centers in the greater Baltimore region and nearby primary care clinics. Of these, 100 had schizophrenia, 101 had a major mood disorder, and 99 had no identified severe mental illness. HbA1c, the main outcome measure, was compared between the group with schizophrenia and the other two groups. RESULTS: All three groups had HbA1c values above recommended levels. HbA1c levels were significantly lower among patients with schizophrenia than among patients who did not have severe mental illness but were not significantly different from those of patients who had major mood disorders. Patients for whom olanzapine was prescribed had higher HbA1c levels than those for whom other antipsychotic agents were prescribed. CONCLUSIONS: All three groups of patients require improved diabetes treatment to achieve acceptable HbA1c levels. There may be previously unrecognized benefits for diabetes management among persons with severe mental illnesses who are receiving regular mental heath care, but these individuals may also have risk factors that can influence diabetes outcomes and HbA1c levels.
This article has been cited by other articles:

|
 |

|
 |
 
J. Kreyenbuhl, L. B. Dixon, J. F. McCarthy, S. Soliman, R. V. Ignacio, and M. Valenstein
Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia?
Schizophr Bull,
August 20, 2008;
(2008)
sbn106v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Druss, S. C. Marcus, J. Campbell, B. Cuffel, J. Harnett, C. Ingoglia, and B. Mauer
Medical Services for Clients in Community Mental Health Centers: Results From a National Survey
Psychiatr Serv,
August 1, 2008;
59(8):
917 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dickerson, C. H. Brown, L. Fang, R. W. Goldberg, J. Kreyenbuhl, K. Wohlheiter, and L. Dixon
Quality of Life in Individuals With Serious Mental Illness and Type 2 Diabetes
Psychosomatics,
April 1, 2008;
49(2):
109 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dickinson, J. M. Gold, F. B. Dickerson, D. Medoff, and L. B. Dixon
Evidence of Exacerbated Cognitive Deficits in Schizophrenia Patients With Comorbid Diabetes
Psychosomatics,
April 1, 2008;
49(2):
123 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Goldberg, B. Cooke, and A. Hackman
Mental Health Providers' Involvement in Diabetes Management
Psychiatr Serv,
November 1, 2007;
58(11):
1501 - 1502.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vandiver
Health Promotion as Brief Treatment: Strategies for Women with Co-morbid Health and Mental Health Conditions
Brief. Treat. Crisis Interven.,
August 23, 2007;
(2007)
mhm009v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Goldberg, J. A. Kreyenbuhl, D. R. Medoff, F. B. Dickerson, K. Wohlheiter, L. J. Fang, C. H. Brown, and L. B. Dixon
Quality of Diabetes Care Among Adults With Serious Mental Illness
Psychiatr Serv,
April 1, 2007;
58(4):
536 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sullivan, X. Han, S. Moore, and K. Kotrla
Disparities in Hospitalization for Diabetes Among Persons With and Without Co-occurring Mental Disorders
Psychiatr Serv,
August 1, 2006;
57(8):
1126 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Weiss, D. C. Henderson, J. B. Weilburg, D. C. Goff, J. B. Meigs, E. Cagliero, and R. W. Grant
Treatment of Cardiac Risk Factors Among Patients With Schizophrenia and Diabetes
Psychiatr Serv,
August 1, 2006;
57(8):
1145 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Krein, C. R. Bingham, J. F. McCarthy, A. Mitchinson, J. Payes, and M. Valenstein
Diabetes Treatment Among VA Patients With Comorbid Serious Mental Illness
Psychiatr Serv,
July 1, 2006;
57(7):
1016 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Piette and E. A. Kerr
The impact of comorbid chronic conditions on diabetes care.
Diabetes Care,
March 1, 2006;
29(3):
725 - 731.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Frayne, J. H. Halanych, D. R. Miller, F. Wang, H. Lin, L. Pogach, E. J. Sharkansky, T. M. Keane, K. M. Skinner, C. S. Rosen, et al.
Disparities in Diabetes Care: Impact of Mental Illness
Arch Intern Med,
December 12, 2005;
165(22):
2631 - 2638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Dickerson, R. W. Goldberg, C. H. Brown, J. A. Kreyenbuhl, K. Wohlheiter, L. Fang, D. Medoff, and L. B. Dixon
Diabetes Knowledge Among Persons With Serious Mental Illness and Type 2 Diabetes
Psychosomatics,
October 1, 2005;
46(5):
418 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|